Evidence map›Paper›PMID 31145992›Full record

ArticleFungal genetics and biology : FG & B2019

Type I and II PRMTs regulate catabolic as well as detoxifying processes in Aspergillus nidulans.

Ingo Bauer, Lukas Lechner, Angelo Pidroni, Anna-Maria Petrone, Petra Merschak, Herbert Lindner, Leopold Kremser, Stefan Graessle, Georg Golderer, Shadab Allipour and 1 more

Abstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ingo BauerDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Lukas LechnerDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Angelo PidroniDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Anna-Maria PetroneDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Petra MerschakDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Herbert LindnerDivision of Clinical Biochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Leopold KremserDivision of Clinical Biochemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Stefan GraessleDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Georg GoldererDivision of Biological Chemistry, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Shadab AllipourDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: shadab.allipour@i-med.ac.at.
Gerald BroschDivision of Molecular Biology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: gerald.brosch@i-med.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In filamentous fungi, arginine methylation has been implicated in morphogenesis, mycotoxin biosynthesis, pathogenicity, and stress response although the exact role of this posttranslational modification in these processes remains obscure. Here, we present the first genome-wide transcriptome analysis in filamentous fungi that compared expression levels of genes regulated by type I and type II protein arginine methyltransferases (PRMTs). In Aspergillus nidulans, three conserved type I and II PRMTs are present that catalyze asymmetric or symmetric dimethylation of arginines. We generated a double type I mutant (ΔrmtA/rmtB) and a combined type I and type II mutant (ΔrmtB/rmtC) to perform genome-wide comparison of their effects on gene expression, but also to monitor putative overlapping activities and reciprocal regulations of type I and type II PRMTs in Aspergillus. Our study demonstrates, that rmtA and rmtC as type I and type II representatives act together as repressors of proteins that are secreted into the extracellular region as the majority of up-regulated genes are mainly involved in catabolic pathways that constitute the secretome of Aspergillus. In addition to a strong up-regulation of secretory genes we found a significant enrichment of down-regulated genes involved in processes related to oxidation-reduction, transmembrane transport and secondary metabolite biosynthesis. Strikingly, nearly 50% of down-regulated genes in both double mutants correspond to redox reaction/oxidoreductase processes, a remarkable finding in light of our recently observed oxidative stress phenotypes of ΔrmtA and ΔrmtC. Finally, analysis of nuclear and cytoplasmic extracts for mono-methylated proteins revealed the presence of both, common and specific substrates of RmtA and RmtC. Thus, our data indicate that type I and II PRMTs in Aspergillus seem to co-regulate the same biological processes but also specifically affect other pathways in a non-redundant fashion.

Indexed as

Genome, FungalAspergillus nidulansGene Expression ProfilingGene Expression Regulation, FungalOxidation-ReductionOxidative StressProtein-Arginine N-MethyltransferasesProtein Processing, Post-TranslationalSecondary MetabolismTranscription FactorsProtein-Arginine N-MethyltransferasesTranscription FactorsAspergillus nidulansFilamentous fungiPosttranslational modificationsProtein arginine methyltransferaseProtein methylation

Identifiers

PMID31145992
PMCPMC6837890

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.